Maja Hellfritzsch
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
Papers in
-
- Atrial Fibrillation Management and Outcomes 16
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Cardiac Arrhythmias and Treatments 3
-
- Venous Thromboembolism Diagnosis and Management 10
- Co-authors
- Anton Pottegård (30 shared papers)Jesper Hallas (19 shared papers)Erik Lerkevang Grove (16 shared papers)Per Damkier (8 shared papers)Lotte Rasmussen (8 shared papers)David Gaist (3 shared papers)Luis A. Garcı́a Rodrı́guez (3 shared papers)Frantz Rom Poulsen (2 shared papers)
- Journals
- Basic & Clinical Pharmacology & Toxicology (10 papers)Pharmacoepidemiology and Drug Safety (5 papers)JAMA (2 papers)EP Europace (2 papers)Seminars in Thrombosis and Hemostasis (2 papers)
- Partner nations
- DenmarkUnited StatesSpain
In The Last Decade
Maja Hellfritzsch
43 papers receiving 846 citations
Peers
Comparison fields: 5 of 85
- Internal Medicine 90
- Cardiology and Cardiovascular Medicine 235
- Neurology 132
- Toxicology 30
- Pharmacology 101
Countries citing papers authored by Maja Hellfritzsch
This map shows the geographic impact of Maja Hellfritzsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Hellfritzsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Hellfritzsch more than expected).
Fields of papers citing papers by Maja Hellfritzsch
This network shows the impact of papers produced by Maja Hellfritzsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Hellfritzsch. The network helps show where Maja Hellfritzsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Maja Hellfritzsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 134 | |
| 2 | 2018 | 86 | |
| 3 | 2019 | 49 | |
| 4 | 2016 | 41 | |
| 5 | 2018 | 37 | |
| 6 | 2016 | 35 | |
| 7 | 2021 | 33 | |
| 8 | 2021 | 27 | |
| 9 | 2016 | 26 | |
| 10 | 2017 | 24 | |
| 11 | 2017 | 24 | |
| 12 | 2016 | 23 | |
| 13 | 2021 | 23 | |
| 14 | 2019 | 22 | |
| 15 | 2021 | 21 | |
| 16 | 2015 | 21 | |
| 17 | 2017 | 19 | |
| 18 | 2015 | 17 | |
| 19 | 2023 | 16 | |
| 20 | 2018 | 15 |
About Maja Hellfritzsch
Maja Hellfritzsch is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Pharmacology, Epidemiology and Economics and Econometrics, having authored 47 papers that have together received 853 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (16 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Cardiac Arrhythmias and Treatments (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Pharmaceutical studies and practices (3 papers), Antifungal resistance and susceptibility (2 papers) and Neurosurgical Procedures and Complications (2 papers). The work is most often cited by research in Internal Medicine (90 citations), Cardiology and Cardiovascular Medicine (235 citations), Neurology (132 citations), Toxicology (30 citations) and Pharmacology (101 citations). Maja Hellfritzsch has collaborated with scholars based in Denmark, United States and Spain. Frequent co-authors include Anton Pottegård, Jesper Hallas, Erik Lerkevang Grove, Per Damkier, Lotte Rasmussen, David Gaist, Luis A. Garcı́a Rodrı́guez, Frantz Rom Poulsen, Bo Halle and Mette Marie Hougaard Christensen. Their work appears in journals such as Basic & Clinical Pharmacology & Toxicology, Pharmacoepidemiology and Drug Safety, JAMA, EP Europace and Seminars in Thrombosis and Hemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.